Winslow Capital Management
LLY icon

Winslow Capital Management’s Eli Lilly LLY Stock Holding History

Winslow Capital Management’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$832M Sell
693,624
-63,962
-8% -$65.4M 2.86% 8
2026
Q1 		$697M Buy
757,586
+358
+0% +$363K 2.72% 8
2025
Q4 		$817M Sell
757,228
-19,905
-3% -$19M 2.74% 8
2025
Q3 		$593M Sell
777,133
-417,673
-35% -$311M 1.96% 18
2025
Q2 		$931M Buy
1,194,806
+54,522
+5% +$42.4M 3.11% 7
2025
Q1 		$942M Buy
1,140,284
+363,944
+47% +$303M 3.76% 7
2024
Q4 		$599M Buy
776,340
+5,227
+0.7% +$4.33M 2.13% 13
2024
Q3 		$683M Buy
771,113
+167,956
+28% +$151M 2.45% 9
2024
Q2 		$546M Buy
603,157
+39,109
+7% +$31.3M 1.97% 15
2024
Q1 		$439M Sell
564,048
-84,923
-13% -$60.4M 1.65% 21
2023
Q4 		$378M Buy
648,971
+2,094
+0.3% +$1.22M 1.57% 20
2023
Q3 		$347M Buy
646,877
+161,509
+33% +$83.2M 1.65% 22
2023
Q2 		$228M Buy
+485,368
New +$204M 1.02% 38
2021
Q1 		– Sell
-1,942,514
Closed -$328M – 67
2020
Q4 		$328M Sell
1,942,514
-417,948
-18% -$62.4M 1.37% 23
2020
Q3 		$349M Sell
2,360,462
-82,670
-3% -$12.8M 1.56% 19
2020
Q2 		$401M Buy
2,443,132
+745,802
+44% +$114M 1.95% 16
2020
Q1 		$235M Buy
+1,697,330
New +$233M 1.44% 26
2019
Q2 		– Sell
-1,741,194
Closed -$226M – 66
2019
Q1 		$226M Buy
1,741,194
+272,003
+19% +$33.1M 1.22% 35
2018
Q4 		$170M Buy
+1,469,191
New +$164M 1.05% 45
2018
Q2 		– Sell
-155
Closed -$12K – 98
2018
Q1 		$12K Sell
155
-2,135,934
-100% -$172M ﹤0.01% 70
2017
Q4 		$180M Sell
2,136,089
-1,674,453
-44% -$142M 0.99% 53
2017
Q3 		$326M Buy
3,810,542
+1,517,677
+66% +$124M 1.76% 22
2017
Q2 		$189M Sell
2,292,865
-1,583,103
-41% -$129M 1% 53
2017
Q1 		$326M Buy
3,875,968
+1,719,538
+80% +$138M 1.56% 25
2016
Q4 		$159M Buy
2,156,430
+2,156,413
+12,684,782% +$161M 0.73% 62
2016
Q3 		$1K Buy
+17
New +$1.36K ﹤0.01% 160

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Winslow Capital Management's LLY Position: Q2 2026 in Review

Winslow Capital Management reduced its Eli Lilly (LLY) stake by 8.4% in Q2 2026, selling an estimated $65.4M and leaving 693,624 shares worth $832M. The position accounts for 2.86% of the portfolio, ranked #8.

Winslow Capital Management first reported a position in LLY in Q3 2016 and has held it in 26 quarters since. The position peaked at $942M in Q1 2025. 4,624 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Winslow Capital Management held 693,624 shares of Eli Lilly worth $832M as of Q2 2026.
  • Winslow Capital Management sold 63,962 Eli Lilly shares in Q2 2026, an estimated $65.4M.
  • Eli Lilly made up 2.86% of Winslow Capital Management's portfolio in Q2 2026, its #8 holding.
  • Winslow Capital Management first reported a position in Eli Lilly in Q3 2016 and has held it in 26 quarters since.
  • Winslow Capital Management's Eli Lilly position peaked at $942M in Q1 2025.
  • 4,624 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Winslow Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.